Methods and systems for presenting an inhalation experience

• US 20100163035A1
• Filed: 03/25/2009
• Published: 07/01/2010
• Est. Priority Date: 12/30/2008
• Status: Active Grant

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Tegreene, Clarence T., Langer, Robert, Lord, Robert W., Wood, Lowell L. JR., Hyde, Roderick A., Sweeney, Elizabeth A., Leuthardt, Eric C.
• Granted Patent: US 8,706,518 B2
• Time in Patent Office: Days
• US Class Current: 128/203.140
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/02 Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/11 Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb for measuring pulse A61B5/02 ;A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/163 by tracking eye movement, gaze, or pupil change
• CPC Class Codes: A61B 5/165 Evaluating the state of mind, e.g. depression, anxiety
• CPC Class Codes: A61B 5/377 using evoked responses
• CPC Class Codes: A61B 5/4064 Evaluating the brain A61B5/031, A61B5/369, A61B5/14553 take precedence
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/486 Bio-feedback A61B5/375 takes precedence
• CPC Class Codes: A61B 5/6822 Neck
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0065 Inhalators with dosage or measuring devices A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 : with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 15/08 : Inhaling devices inserted into the nose
• CPC Class Codes: A61M 2021/0016 : by the smell sense
• CPC Class Codes: A61M 2205/3553 : remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3569 : sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3584 : using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/3592 : using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/50 : with microprocessors or computers
• CPC Class Codes: A61M 2205/581 : by audible feedback
• CPC Class Codes: A61M 2205/582 : by tactile feedback
• CPC Class Codes: A61M 2205/583 : by visual feedback
• CPC Class Codes: A61M 2205/588 : by olfactory feedback, i.e. smell
• CPC Class Codes: A61M 2209/088 : on the body
• CPC Class Codes: A61M 2230/201 : Glucose concentration
• CPC Class Codes: A61M 2230/205 : partial oxygen pressure (P-O2)
• CPC Class Codes: A63F 2300/65 : for computing the condition of a game character
• CPC Class Codes: A63F 2300/6692 : using special effects, generally involving post-processing, e.g. blooming
• CPC Class Codes: G16H 20/13 : delivered from dispensers
• CPC Class Codes: G16H 40/67 : for remote operation
• CPC Class Codes: G16H 70/40 : relating to drugs, e.g. their side effects or intended usage

Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual and presenting at Least one artificial sensory experience to monitor at Least one side effect of the bioactive agent on the individual.

Claims

1. A system, comprising:

means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual; and

means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

2. The system of claim 1 wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of a bioactive agent-dispensing inhalation device configured to interface with a computing device.

3. The system of claim 2 wherein the means for accepting an indication of a bioactive agent-dispensing inhalation device configured to interface with a computing device comprises:

means for accepting an indication of a bioactive agent-dispensing inhalation device configured to interface wirelessly with a computing device.

4. The system of claim 1, wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of a bioactive agent-dispensing inhalation collar.

5. The system of claim 1, wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of a bioactive agent-dispensing virtual-reality headset.

6. The system of claim 5, wherein the means for accepting an indication of a bioactive agent-dispensing virtual-reality headset comprises:

means for accepting at least one of a bioactive agent dosing schedule or a bioactive agent administration schedule.

7. The system of claim 1, wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of a medication-dispensing inhalation device.

8. The system of claim 7, wherein the means for accepting an indication of a medication-dispensing inhalation device comprises:

means for accepting an indication of a prescription medication-dispensing inhalation device.

10. The system of claim 1, wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of an unregulated bioactive agent-dispensing inhalation device.

12. The system of claim 1, wherein the means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual comprises:

means for accepting an indication of a recreational bioactive agent-dispensing inhalation device.

14. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for receiving data from an automated medical device.

15. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting a sensate experience.

17. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting an artificial sensory experience implemented on a mobile device.

18. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting a virtual world, a modification to a virtual world, a computer game, a modification to a computer game, a website, a modification to a website, an online course, or a modification to an online course.

19. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting an artificial sensory experience to monitor at least one of physical activity, body weight, body mass index, heart rate, blood oxygen level, or blood pressure temporally associated with an artificial sensory experience.

20. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting an artificial sensory experience to monitor a neurophysiological measurement.

22. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for measuring at least one brain activity surrogate marker.

24. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for presenting an artificial sensory experience to measure at least one effect of the bioactive agent in at least one of near real time or real time.

25. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for monitoring at least one of visual field test function output, eye movement test function output, pupil movement test function output, face pattern test function output, hearing test function output, or voice test function output.

26. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for monitoring at least one of body movement test function output or motor skill test function output.

27. The system of claim 1, wherein the means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprises:

means for recording at least one monitored effect of the bioactive agent.

28. The system of claim 1, wherein means for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual and means for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual comprise:

means for accepting an indication of a collar configured to dispense a bronchodilator to an individual and presenting a virtual world to monitor an individual'"'"'s hypertension in response to administration of the bronchodilator.

29. The system of claim 1, further comprising:

means for reporting at least one monitored effect.

35. The system of claim 1, further comprising:

means for predicting at least one effect of the bioactive agent when combined with the artificial sensory experience.

9. canceled

11. canceled

13. canceled

16. canceled

21. canceled

23. canceled

30-34. -34. (canceled)

36-37. -37. (canceled)

38. A computer-implemented method, comprising:

accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual; and

presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

39-74. -74. (canceled)

75. A system, comprising:

circuitry for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual; and

circuitry for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

76. A computer program product comprising:

a signal-bearing medium bearing one or more instructions for accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual; and

one or more instructions for presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

77. The computer program product of claim 76, wherein the signal-bearing medium includes a computer-readable medium.

78. The computer program product of claim 76, wherein the signal-bearing medium includes a recordable medium.

79. The computer program product of claim 76, wherein the signal-bearing medium includes a communications medium.

80. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

accept at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual; and

present at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

81. The system of claim 80 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

82. The system of claim 80, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.